Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 5
2018 8
2019 7
2020 1
2021 6
2022 17
2023 12
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Réponse à la lettre d’A. Braillon et F. Taiebi.
de Nonneville A, Gonçalves A. de Nonneville A, et al. Bull Cancer. 2018 Jul-Aug;105(7-8):641-642. doi: 10.1016/j.bulcan.2018.06.001. Epub 2018 Jun 22. Bull Cancer. 2018. PMID: 29937335 French. No abstract available.
Sacituzumab govitecan in triple-negative breast cancer.
de Nonneville A, Goncalves A, Mamessier E, Bertucci F. de Nonneville A, et al. Ann Transl Med. 2022 Jun;10(11):647. doi: 10.21037/atm-22-813. Ann Transl Med. 2022. PMID: 35813338 Free PMC article. No abstract available.
[Cancer: The need to believe].
Garciaz S, de Nonneville A, Maraninchi D. Garciaz S, et al. Among authors: de nonneville a. Bull Cancer. 2024 Jun;111(6):550-551. doi: 10.1016/j.bulcan.2024.04.001. Epub 2024 May 6. Bull Cancer. 2024. PMID: 38714464 French. No abstract available.
"Wnt/β-Catenin in GIST"-Letter.
Bertucci F, Finetti P, De Nonneville A, Birnbaum D. Bertucci F, et al. Among authors: de nonneville a. Mol Cancer Ther. 2018 Jan;17(1):327-328. doi: 10.1158/1535-7163.MCT-17-0948. Mol Cancer Ther. 2018. PMID: 29295963
Tucatinib Combination Treatment After Trastuzumab-Deruxtecan in Patients With ERBB2-Positive Metastatic Breast Cancer.
Frenel JS, Zeghondy J, Guérin-Charbonnel C, Mailliez A, Volant E, Poumeaud F, Patsouris A, Arnedos M, Bailleux C, Cabal J, Galland L, de Nonneville A, Guiu S, Dalenc F, Pistilli B, Bachelot T, Pierga JY, Le Du F, Bocquet F, Larrouquere L, Loirat D. Frenel JS, et al. Among authors: de nonneville a. JAMA Netw Open. 2024 Apr 1;7(4):e244435. doi: 10.1001/jamanetworkopen.2024.4435. JAMA Netw Open. 2024. PMID: 38568692 Free PMC article.
Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer.
Poumeaud F, Morisseau M, Cabel L, Gonçalves A, Rivier C, Trédan O, Volant E, Frenel JS, Ladoire S, Jacot W, Jamelot M, Foka Tichoue H, Patsouris A, Teixeira L, Bidard FC, Loirat D, Brunet M, Levy C, Bailleux C, Cabarrou B, Deleuze A, Uwer L, Deluche E, Grellety T, Franchet C, Fiteni F, Bischoff H, Vion R, Pagliuca M, Verret B, Bécourt S, Reverdy T, de Nonneville A, Dalenc F. Poumeaud F, et al. Among authors: de nonneville a. Br J Cancer. 2024 Sep;131(4):702-708. doi: 10.1038/s41416-024-02766-9. Epub 2024 Jun 25. Br J Cancer. 2024. PMID: 38918555
[A 2023 inventory in oncology news].
Bay JO, Auberger B, Bouleuc C, Cohen R, Delom F, Firmin N, Gandemer V, L'Allemain G, Magne N, De Nonneville A, Orbach D, Pellier I, Rodrigues M, Wislez M; pour le comité de rédaction du Bulletin du Cancer. Bay JO, et al. Among authors: de nonneville a. Bull Cancer. 2024 Jan;111(1):18-32. doi: 10.1016/j.bulcan.2023.12.003. Epub 2024 Jan 5. Bull Cancer. 2024. PMID: 38184423 Review. French.
66 results